This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Liwei Liu - Innovator in Medicinal Chemistry
Introduction
Liwei Liu is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on polyethylene glycol conjugate medicaments. His research focuses on the preparation methods and applications of these medicaments, which have important implications for pharmaceutical development.
Latest Patents
Liwei Liu holds a patent for a polyethylene glycol conjugate medicament, which includes a preparation method and its uses. This invention is particularly notable for its representation by a specific formula and its potential as a pharmaceutically acceptable salt. The patent outlines a method for preparing the medicament, along with a pharmaceutical composition that incorporates it, highlighting its utility in the development of new medications.
Career Highlights
Liwei Liu is associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to advance his research in medicinal chemistry. His work has garnered attention for its innovative approach to drug formulation and delivery, contributing to the broader field of pharmaceutical sciences.
Collaborations
Liwei Liu has collaborated with notable colleagues, including Gaoquan Li and Dajun Li. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research efforts.
Conclusion
Liwei Liu's contributions to the field of medicinal chemistry, particularly through his patent on polyethylene glycol conjugate medicaments, underscore his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile